PharmaShots | Incisive News in 3 Shots

Subscribe Now

Cardiovascular events

Regeneron and Sanofi Announces Acceptance of sBLA for PRALUENT's by the US for the Treatment of Reduction in MACE

Regeneron and Sanofi Announces Acceptance of sBLA for PRALUENT's by the US for the Treatment of Reduction in MACE

September 12, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us